Tuberculoma, Intracranial
Tuberculosis, Cardiovascular
Tuberculosis, Meningeal
Tuberculosis, Central Nervous System
Tuberculosis, Ocular
Tuberculosis, Hepatic
Spinal Cord Diseases
Antitubercular Agents
Scleral Diseases
Brain Diseases
Pituitary Diseases
Tuberculosis, Spinal
Magnetic Resonance Imaging
Meningioma
Sella Turcica
Tomography, X-Ray Computed
Intradural extramedullary tuberculoma of the spinal cord: a case report. (1/91)
Intradural extramedullary (IDEM) tuberculoma of the spinal cord is uncommon entity and moreover, few reports have been documented on concurrent IDEM and intracranial tuberculomas. Authors report a case of IDEM spinal tuberculoma having intracranial lesion simultaneously. A 49-year-old woman suffered from paraparesis and urinary incontinence while being given medical treatment for tuberculous meningitis. Magnetic resonance imaging (MRI) revealed an IDEM mass lesion between the T1 and T2 spinal levels, and multiple intracranial tuberculous granulomas. Surgical resection of the IDEM tuberculoma followed by anti-tuberculous medication resulted in good outcome. (+info)Restraining mycobacteria: role of granulomas in mycobacterial infections. (2/91)
The generation of prolonged immunity to Mycobacterium tuberculosis requires not only an antigen-specific IFN-gamma-producing T cell response, including both CD4 and CD8 T cells, but also the generation of protective granulomatous lesions, whereby the close apposition of activated T cells and macrophages acts to contain bacterial growth. The importance of the granulomatous lesion in controlling this immune response and in limiting both tissue damage and bacterial dissemination has been considered a secondary event but, as the present review illustrates, is no less important in surviving mycobacterial infection than an antigen-specific T-cell response. The formation of a protective granuloma involves the orchestrated production of a host of chemokines and cytokines, the upregulation of their receptors along with upregulation of addressins, selectins and integrins to coordinate the recruitment, migration and retention of cells to and within the granuloma. In the present review, the principal components of the protective response are outlined and the role of granuloma formation and maintenance in mediating prolonged containment of mycobacteria within the lung is addressed. (+info)A novel tumor necrosis factor (TNF) mimetic peptide prevents recrudescence of Mycobacterium bovis bacillus Calmette-Guerin (BCG) infection in CD4+ T cell-depleted mice. (3/91)
Tumor necrosis factor (TNF) is required to control mycobacterial infections, but its therapeutic value is limited by its in vivo instability and toxicity. The efficacy of a nontoxic TNF-mimetic peptide (TNF70-80) was tested in mice infected with Mycobacterium bovis bacillus Callette-Guerin (BCG). In vitro TNF70-80 and recombinant human TNF (hTNF) acted with interferon gamma (IFN-gamma) to reduce bacterial replication and to induce synthesis of bactericidal nitric oxide (NO) in BCG-infected, bone marrow-derived murine macrophages. The dose-dependent inhibitory effect on bacterial replication was blocked by neutralizing anti-IFN-gamma and anti-hTNF mAbs. Further, n-monomethyl-L-arginine (n-MMA) and a soluble TNF-receptor I (TNFRI-IgG) blocked bacterial growth and NO synthesis. Therefore, the peptide acted with IFN-gamma via induction of NO synthase and signaled through TNFRI receptors. Concomitant in vivo treatment with TNF70-80 or hTNF prevented reactivation of chronic BCG infection in mice depleted of CD4+ T cells by injecting anti-CD4 antibodies. Granuloma number and bacterial load were comparable in treated, T cell-depleted mice and in chronically infected, intact animals. Thus, TNF70-80 and hTNF can modulate recrudescent BCG infection in CD4+ T cell-deficient mice. (+info)Sarcoid reaction in primary tumor of bronchogenic large cell carcinoma accompanied with massive necrosis. (4/91)
A 49-year-old woman consulted our hospital for evaluation of a tumor with cavitation in the S6 segment of the right lung. She was given a diagnosis of pulmonary tuberculoma because percutaneous needle aspiration cytology revealed epithelioid cells with a background of necrosis. However, a diagnosis of large cell carcinoma with central necrosis (p-T2NOM0) was established by thoracoscopic lung biopsy six months later. Pathological findings of surgical resection specimens showed that epithelioid cell granulomas adjacent to the neoplasm had a sarcoid reaction and the necrosis was related to the rapidly growing tumor because there was no clinical evidence of systemic sarcoidosis and pulmonary mycobacterial or fungal infection. This is the first report in which sarcoid reactions were recognized in a primary large cell carcinoma. (+info)Granulomatous skin lesions in moray eels caused by a novel Mycobacterium species related to Mycobacterium triplex. (5/91)
An outbreak of granulomatous dermatitis was investigated in a captive population of moray eels. The affected eels had florid skin nodules concentrated around the head and trunk. Histopathological examination revealed extensive granulomatous inflammation within the dermis and subcutaneous fascial plane between the fat and axial musculature. Acid-fast rods were detected within the smallest lesions, which were presumably the ones that had developed earliest. Eventually, after several months of incubation at room temperature, a very slowly growing acid-fast organism was isolated. Sequencing of the 16S rRNA gene identified it as a Mycobacterium species closely related (0.59% divergence) to M. triplex, an SAV mycobacterium. Intradermal inoculation of healthy green moray eels with this organism reliably reproduced the lesion. Experimentally induced granulomatous dermatitis appeared within 2 weeks of inoculation and slowly but progressively expanded during the 2 months of the experiment. Live organisms were recovered from these lesions at all time points, fulfilling Koch's postulates for this bacterium. In a retrospective study of tissues collected between 1993 and 1999 from five spontaneous disease cases, acid-fast rods were consistently found within lesions, and a nested PCR for the rRNA gene also demonstrated the presence of mycobacteria within affected tissues. (+info)Intracranial tuberculoma--an increasing problem in Britain. (6/91)
Ten cases of intracranial tuberculoma are described. These were investigated and treated at one centre in a 20 year period. The last five cases have occurred in immigrant Asians in the last five years, suggesting an increasing incidence. Diagnostic pointers are discussed and the value of brain scanning emphasized. (+info)Choroidal tuberculoma with membranous glomerulonephritis. (7/91)
We report treatment of a 24-year-old man with membranous glomerulonephritis (MGN) who developed a solitary choroidal tuberculoma in association with miliary tuberculosis during steroid therapy. In June 1995, the patient had developed nephrotic syndrome. He had refused renal biopsy at that time. So we treated him with corticosteroids having assumed a diagnosis of minimal change nephrotic syndrome. After initial corticosteroids and diuretics therapy for 5 months, his generalized edema resolved but proteinuria (3 positive) continued, suggesting the presence of other forms of glomerulonephritis. Renal biopsy performed in January 1996. The patient was diagnosed as having MGN. The patient was closely observed over a period of 34 months and remained stable without steroid therapy. However at 34 months, generalized edema was again noted and steroid therapy at high dosage was initiated. After 5 months of steroid therapy, he developed miliary tuberculosis and a solitary choroidal mass. An antituberculosis chemotherapeutic regimen was started and after a further 5 months, all clinical symptoms and signs of the pulmonary lesion were resolved and a measurable shrinking of the choroidal mass was recorded. (+info)Pituitary tuberculoma--a case report. (8/91)
Pituitary tuberculomas, mimicking adenomas are very unusual. We describe a rare case of a patient with an exclusively intrasellar mass, and who presented with severe headaches and loss of libido. The lesion was approached trans-sphenoidally and pathological examination revealed a tuberculoma. Complete removal was achieved and the patient followed on anti-tuberculous therapy. (+info)A tuberculoma is a granulomatous lesion in the brain caused by the infection of Mycobacterium tuberculosis. It typically consists of caseating necrosis surrounded by a layer of epithelioid histiocytes, Langhans' giant cells, and lymphocytes. Tuberculomas can be single or multiple and may cause various neurological symptoms depending on their size and location. They are often associated with tuberculous meningitis but can also occur in immunocompromised individuals without obvious systemic infection.
A tuberculoma is a specific type of granulomatous lesion that occurs in the brain due to infection with the Mycobacterium tuberculosis bacterium. This condition is relatively rare in developed countries but is still common in developing nations where tuberculosis (TB) is prevalent.
Intracranial tuberculomas are formed when M. tuberculosis bacteria spread through the bloodstream from a primary focus, usually in the lungs, and lodge in the brain tissue. The bacteria then multiply within the brain, leading to an inflammatory response characterized by the formation of granulomas. These granulomas consist of central caseous necrosis (cheese-like material) surrounded by a layer of epithelioid histiocytes, lymphocytes, and multinucleated giant cells.
Tuberculomas can vary in size from a few millimeters to several centimeters in diameter. They may be solitary or multiple and are often found near the surface of the brain, particularly in the cerebral cortex or meninges (the protective membranes surrounding the brain). The presence of intracranial tuberculomas can lead to various neurological symptoms, such as headaches, seizures, focal deficits, and cognitive impairment.
Diagnosis of intracranial tuberculomas typically involves a combination of imaging techniques (such as CT or MRI scans) and laboratory tests (such as cerebrospinal fluid analysis and PCR for M. tuberculosis). Treatment usually consists of a prolonged course of anti-tuberculous medications, which can help to reduce the size of the lesions and alleviate symptoms. In some cases, surgical intervention may be necessary to remove or decompress large or symptomatic tuberculomas.
"Cardiovascular Tuberculosis" refers to a form of tuberculosis (TB) where the bacteria (Mycobacterium tuberculosis) infects the heart or the blood vessels. This is a less common manifestation of TB, but it can have serious consequences if left untreated.
In cardiovascular TB, the bacteria can cause inflammation and damage to the heart muscle (myocarditis), the sac surrounding the heart (pericarditis), or the coronary arteries that supply blood to the heart muscle. This can lead to symptoms such as chest pain, shortness of breath, coughing, fatigue, and fever. In severe cases, it can cause heart failure or life-threatening arrhythmias.
Cardiovascular TB is usually treated with a combination of antibiotics that are effective against the TB bacteria. The treatment may last for several months to ensure that all the bacteria have been eliminated. In some cases, surgery may be necessary to repair or replace damaged heart valves or vessels. Early diagnosis and treatment can help prevent serious complications and improve outcomes in patients with cardiovascular TB.
Meningeal tuberculosis, also known as Tuberculous meningitis, is a severe form of tuberculosis (TB) that affects the meninges, which are the membranes covering the brain and spinal cord. It is caused by the Mycobacterium tuberculosis bacterium, which can spread through the bloodstream from a primary infection site in the lungs or elsewhere in the body.
In meningeal tuberculosis, the bacteria cause inflammation and thickening of the meninges, leading to increased intracranial pressure, cerebral edema, and vasculitis. These conditions can result in various neurological symptoms such as headache, fever, stiff neck, altered mental status, seizures, and focal neurologic deficits. If left untreated, meningeal tuberculosis can lead to severe complications, including brain damage, hydrocephalus, and even death.
Diagnosis of meningeal tuberculosis typically involves a combination of clinical symptoms, cerebrospinal fluid (CSF) analysis, imaging studies, and sometimes molecular or culture-based tests to detect the presence of Mycobacterium tuberculosis in the CSF. Treatment usually involves a prolonged course of antibiotics specifically designed to target TB, such as isoniazid, rifampin, ethambutol, and pyrazinamide, often administered for six to nine months or longer. In some cases, corticosteroids may also be used to reduce inflammation and prevent complications.
Central Nervous System (CNS) Tuberculosis is a specific form of tuberculosis (TB) that refers to the infection and inflammation caused by Mycobacterium tuberculosis in the brain or spinal cord. The two most common forms of CNS tuberculosis are tuberculous meningitis and tuberculomas.
1. Tuberculous Meningitis (TBM): This is the most frequent form of CNS TB, characterized by the inflammation of the membranes surrounding the brain and spinal cord (meninges). The infection can lead to the formation of caseous lesions (granulomas), which may obstruct cerebrospinal fluid (CSF) flow and result in increased intracranial pressure. Symptoms often include headache, fever, altered mental status, neck stiffness, vomiting, and focal neurological deficits.
2. Tuberculomas: These are localized granulomatous lesions formed by the immune response to M. tuberculosis in the brain parenchyma. They can cause various neurological symptoms depending on their size and location, such as seizures, focal deficits, or increased intracranial pressure.
CNS TB is a severe manifestation of tuberculosis that requires prompt diagnosis and treatment to prevent long-term neurological damage or even death. Diagnosis typically involves imaging studies (CT or MRI scans) and analysis of cerebrospinal fluid obtained through lumbar puncture. Treatment usually consists of a prolonged course of multiple antituberculous drugs, along with corticosteroids to manage inflammation and prevent complications.
Ocular tuberculosis (OTB) is a form of extrapulmonary tuberculosis (TB), which results from the spread of Mycobacterium tuberculosis complex bacteria outside the lungs. In ocular tuberculosis, these bacteria primarily affect the eye and its surrounding structures.
The most common form of OTB is tubercular uveitis, which involves inflammation of the uveal tract (iris, ciliary body, and choroid). Other forms of OTB include:
* Tubercular conjunctivitis: Inflammation of the conjunctiva, the mucous membrane that covers the front part of the eye and lines the inside of the eyelids.
* Tubercular keratitis: Inflammation of the cornea, the transparent outer layer at the front of the eye.
* Tubercular scleritis: Inflammation of the sclera, the white protective coating of the eye.
* Tubercular episcleritis: Inflammation of the episclera, a thin layer of tissue between the conjunctiva and sclera.
* Tubercular dacryoadenitis: Inflammation of the lacrimal gland, which produces tears.
* Tubercular optic neuritis: Inflammation of the optic nerve, which transmits visual information from the eye to the brain.
Diagnosis of OTB can be challenging due to its varied clinical presentations and the need for laboratory confirmation. A definitive diagnosis typically requires the isolation of Mycobacterium tuberculosis from ocular tissues or fluids, which may involve invasive procedures. In some cases, a presumptive diagnosis might be made based on clinical findings, epidemiological data, and response to anti-tuberculous therapy.
Treatment for OTB usually involves a standard anti-tuberculosis regimen consisting of multiple drugs (isoniazid, rifampin, ethambutol, and pyrazinamide) for at least six months. Corticosteroids or other immunosuppressive agents might be used concomitantly to manage inflammation and prevent tissue damage. Close monitoring is essential to ensure treatment adherence, assess response to therapy, and detect potential side effects.
Hepatic tuberculosis (HTB) is a form of extrapulmonary tuberculosis (TB) that involves the liver. It can occur as a result of the spread of Mycobacterium tuberculosis from a primary site of infection, usually the lungs, through the bloodstream to the liver.
In hepatic tuberculosis, the liver may become enlarged and tender, and patients may experience symptoms such as fever, night sweats, loss of appetite, weight loss, and abdominal discomfort. Liver function tests may show elevated levels of certain enzymes, such as alkaline phosphatase and gamma-glutamyl transferase (GGT).
Diagnosis of hepatic tuberculosis can be challenging, as the symptoms and laboratory findings are nonspecific. Imaging studies such as ultrasound, CT scan, or MRI may show evidence of liver involvement, but a definitive diagnosis usually requires histological examination of liver tissue obtained through biopsy.
Treatment of hepatic tuberculosis involves the use of multiple antituberculous drugs, typically including isoniazid, rifampin, ethambutol, and pyrazinamide. The duration of treatment is usually at least six months, but may be longer in some cases. It is important to monitor liver function tests closely during treatment, as these medications can cause liver damage in some individuals.
Spinal cord diseases refer to a group of conditions that affect the spinal cord, which is a part of the central nervous system responsible for transmitting messages between the brain and the rest of the body. These diseases can cause damage to the spinal cord, leading to various symptoms such as muscle weakness, numbness, pain, bladder and bowel dysfunction, and difficulty with movement and coordination.
Spinal cord diseases can be congenital or acquired, and they can result from a variety of causes, including infections, injuries, tumors, degenerative conditions, autoimmune disorders, and genetic factors. Some examples of spinal cord diseases include multiple sclerosis, spina bifida, spinal cord injury, herniated discs, spinal stenosis, and motor neuron diseases such as amyotrophic lateral sclerosis (ALS).
The treatment for spinal cord diseases varies depending on the underlying cause and severity of the condition. Treatment options may include medication, physical therapy, surgery, and rehabilitation. In some cases, the damage to the spinal cord may be irreversible, leading to permanent disability or paralysis.
Antitubercular agents, also known as anti-tuberculosis drugs or simply TB drugs, are a category of medications specifically used for the treatment and prevention of tuberculosis (TB), a bacterial infection caused by Mycobacterium tuberculosis. These drugs target various stages of the bacteria's growth and replication process to eradicate it from the body or prevent its spread.
There are several first-line antitubercular agents, including:
1. Isoniazid (INH): This is a bactericidal drug that inhibits the synthesis of mycolic acids, essential components of the mycobacterial cell wall. It is primarily active against actively growing bacilli.
2. Rifampin (RIF) or Rifampicin: A bactericidal drug that inhibits DNA-dependent RNA polymerase, preventing the transcription of genetic information into mRNA. This results in the interruption of protein synthesis and ultimately leads to the death of the bacteria.
3. Ethambutol (EMB): A bacteriostatic drug that inhibits the arabinosyl transferase enzyme, which is responsible for the synthesis of arabinan, a crucial component of the mycobacterial cell wall. It is primarily active against actively growing bacilli.
4. Pyrazinamide (PZA): A bactericidal drug that inhibits the synthesis of fatty acids and mycolic acids in the mycobacterial cell wall, particularly under acidic conditions. PZA is most effective during the initial phase of treatment when the bacteria are in a dormant or slow-growing state.
These first-line antitubercular agents are often used together in a combination therapy to ensure complete eradication of the bacteria and prevent the development of drug-resistant strains. Treatment duration typically lasts for at least six months, with the initial phase consisting of daily doses of INH, RIF, EMB, and PZA for two months, followed by a continuation phase of INH and RIF for four months.
Second-line antitubercular agents are used when patients have drug-resistant TB or cannot tolerate first-line drugs. These include drugs like aminoglycosides (e.g., streptomycin, amikacin), fluoroquinolones (e.g., ofloxacin, moxifloxacin), and injectable bacteriostatic agents (e.g., capreomycin, ethionamide).
It is essential to closely monitor patients undergoing antitubercular therapy for potential side effects and ensure adherence to the treatment regimen to achieve optimal outcomes and prevent the development of drug-resistant strains.
Scleral diseases refer to conditions that affect the sclera, which is the tough, white outer coating of the eye. The sclera helps to maintain the shape of the eye and provides protection for the internal structures. Scleral diseases can cause inflammation, degeneration, or thinning of the sclera, leading to potential vision loss or other complications. Some examples of scleral diseases include:
1. Scleritis: an inflammatory condition that causes pain, redness, and sensitivity in the affected area of the sclera. It can be associated with autoimmune disorders, infections, or trauma.
2. Episcleritis: a less severe form of inflammation that affects only the episclera, a thin layer of tissue overlying the sclera. Symptoms include redness and mild discomfort but typically no pain.
3. Pinguecula: a yellowish, raised deposit of protein and fat that forms on the conjunctiva, the clear membrane covering the sclera. While not a disease itself, a pinguecula can cause irritation or discomfort and may progress to a more severe condition called a pterygium.
4. Pterygium: a fleshy growth that extends from the conjunctiva onto the cornea, potentially obstructing vision. It is often associated with prolonged sun exposure and can be removed surgically if it becomes problematic.
5. Scleral thinning or melting: a rare but serious condition where the sclera degenerates or liquefies, leading to potential perforation of the eye. This can occur due to autoimmune disorders, infections, or as a complication of certain surgical procedures.
6. Ocular histoplasmosis syndrome (OHS): a condition caused by the Histoplasma capsulatum fungus, which can lead to scarring and vision loss if it involves the macula, the central part of the retina responsible for sharp, detailed vision.
It is essential to consult an ophthalmologist or eye care professional if you experience any symptoms related to scleral diseases to receive proper diagnosis and treatment.
Brain diseases, also known as neurological disorders, refer to a wide range of conditions that affect the brain and nervous system. These diseases can be caused by various factors such as genetics, infections, injuries, degeneration, or structural abnormalities. They can affect different parts of the brain, leading to a variety of symptoms and complications.
Some examples of brain diseases include:
1. Alzheimer's disease - a progressive degenerative disorder that affects memory and cognitive function.
2. Parkinson's disease - a movement disorder characterized by tremors, stiffness, and difficulty with coordination and balance.
3. Multiple sclerosis - a chronic autoimmune disease that affects the nervous system and can cause a range of symptoms such as vision loss, muscle weakness, and cognitive impairment.
4. Epilepsy - a neurological disorder characterized by recurrent seizures.
5. Brain tumors - abnormal growths in the brain that can be benign or malignant.
6. Stroke - a sudden interruption of blood flow to the brain, which can cause paralysis, speech difficulties, and other neurological symptoms.
7. Meningitis - an infection of the membranes surrounding the brain and spinal cord.
8. Encephalitis - an inflammation of the brain that can be caused by viruses, bacteria, or autoimmune disorders.
9. Huntington's disease - a genetic disorder that affects muscle coordination, cognitive function, and mental health.
10. Migraine - a neurological condition characterized by severe headaches, often accompanied by nausea, vomiting, and sensitivity to light and sound.
Brain diseases can range from mild to severe and may be treatable or incurable. They can affect people of all ages and backgrounds, and early diagnosis and treatment are essential for improving outcomes and quality of life.
Pituitary diseases refer to a group of conditions that affect the pituitary gland, a small endocrine gland located at the base of the brain. The pituitary gland is responsible for producing and secreting several important hormones that regulate various bodily functions, including growth and development, metabolism, stress response, and reproduction.
Pituitary diseases can be classified into two main categories:
1. Pituitary tumors: These are abnormal growths in or around the pituitary gland that can affect its function. Pituitary tumors can be benign (non-cancerous) or malignant (cancerous), and they can vary in size. Some pituitary tumors produce excess hormones, leading to a variety of symptoms, while others may not produce any hormones but can still cause problems by compressing nearby structures in the brain.
2. Pituitary gland dysfunction: This refers to conditions that affect the normal function of the pituitary gland without the presence of a tumor. Examples include hypopituitarism, which is a condition characterized by decreased production of one or more pituitary hormones, and Sheehan's syndrome, which occurs when the pituitary gland is damaged due to severe blood loss during childbirth.
Symptoms of pituitary diseases can vary widely depending on the specific condition and the hormones that are affected. Treatment options may include surgery, radiation therapy, medication, or a combination of these approaches.
Tuberculosis (TB) of the spine, also known as Pott's disease, is a specific form of extrapulmonary tuberculosis that involves the vertebral column. It is caused by the Mycobacterium tuberculosis bacterium, which primarily affects the lungs but can spread through the bloodstream to other parts of the body, including the spine.
In Pott's disease, the infection leads to the destruction of the spongy bone (vertebral body) and the intervertebral disc space, resulting in vertebral collapse, kyphosis (hunchback deformity), and potential neurological complications due to spinal cord compression. Common symptoms include back pain, stiffness, fever, night sweats, and weight loss. Early diagnosis and treatment with a multidrug antibiotic regimen are crucial to prevent long-term disability and further spread of the infection.
Pyrazinamide is an antituberculosis agent, a type of medication used to treat tuberculosis (TB) caused by Mycobacterium tuberculosis. It is an antimicrobial drug that works by inhibiting the growth of the bacterium. Pyrazinamide is often used in combination with other TB drugs such as isoniazid, rifampin, and ethambutol.
The medical definition of Pyrazinamide is: a synthetic antituberculosis agent, C6H5N3O (a pyridine derivative), used in the treatment of tuberculosis, especially in combination with isoniazid and rifampin. It is converted in the body to its active form, pyrazinoic acid, which inhibits the growth of Mycobacterium tuberculosis by interfering with bacterial cell wall synthesis.
It's important to note that Pyrazinamide should be used under the supervision of a healthcare professional and is usually prescribed for several months to ensure complete eradication of the TB bacteria. As with any medication, it can cause side effects, and individuals should report any unusual symptoms to their healthcare provider.
Medical Definition:
Magnetic Resonance Imaging (MRI) is a non-invasive diagnostic imaging technique that uses a strong magnetic field and radio waves to create detailed cross-sectional or three-dimensional images of the internal structures of the body. The patient lies within a large, cylindrical magnet, and the scanner detects changes in the direction of the magnetic field caused by protons in the body. These changes are then converted into detailed images that help medical professionals to diagnose and monitor various medical conditions, such as tumors, injuries, or diseases affecting the brain, spinal cord, heart, blood vessels, joints, and other internal organs. MRI does not use radiation like computed tomography (CT) scans.
A meningioma is a type of slow-growing tumor that forms on the membranes (meninges) surrounding the brain and spinal cord. It's usually benign, meaning it doesn't spread to other parts of the body, but it can still cause serious problems if it grows and presses on nearby tissues.
Meningiomas most commonly occur in adults, and are more common in women than men. They can cause various symptoms depending on their location and size, including headaches, seizures, vision or hearing problems, memory loss, and changes in personality or behavior. In some cases, they may not cause any symptoms at all and are discovered only during imaging tests for other conditions.
Treatment options for meningiomas include monitoring with regular imaging scans, surgery to remove the tumor, and radiation therapy to shrink or kill the tumor cells. The best treatment approach depends on factors such as the size and location of the tumor, the patient's age and overall health, and their personal preferences.
The Sella Turcica, also known as the Turkish saddle, is a depression or fossa in the sphenoid bone located at the base of the skull. It forms a housing for the pituitary gland, which is a small endocrine gland often referred to as the "master gland" because it controls other glands and makes several essential hormones. The Sella Turcica has a saddle-like shape, with its anterior and posterior clinoids forming the front and back of the saddle, respectively. This region is of significant interest in neuroimaging and clinical settings, as various conditions such as pituitary tumors or other abnormalities may affect the size, shape, and integrity of the Sella Turcica.
X-ray computed tomography (CT or CAT scan) is a medical imaging method that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional (tomographic) images (virtual "slices") of the body. These cross-sectional images can then be used to display detailed internal views of organs, bones, and soft tissues in the body.
The term "computed tomography" is used instead of "CT scan" or "CAT scan" because the machines take a series of X-ray measurements from different angles around the body and then use a computer to process these data to create detailed images of internal structures within the body.
CT scanning is a noninvasive, painless medical test that helps physicians diagnose and treat medical conditions. CT imaging provides detailed information about many types of tissue including lung, bone, soft tissue and blood vessels. CT examinations can be performed on every part of the body for a variety of reasons including diagnosis, surgical planning, and monitoring of therapeutic responses.
In computed tomography (CT), an X-ray source and detector rotate around the patient, measuring the X-ray attenuation at many different angles. A computer uses this data to construct a cross-sectional image by the process of reconstruction. This technique is called "tomography". The term "computed" refers to the use of a computer to reconstruct the images.
CT has become an important tool in medical imaging and diagnosis, allowing radiologists and other physicians to view detailed internal images of the body. It can help identify many different medical conditions including cancer, heart disease, lung nodules, liver tumors, and internal injuries from trauma. CT is also commonly used for guiding biopsies and other minimally invasive procedures.
In summary, X-ray computed tomography (CT or CAT scan) is a medical imaging technique that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional images of the body. It provides detailed internal views of organs, bones, and soft tissues in the body, allowing physicians to diagnose and treat medical conditions.
Neurosurgical procedures are operations that are performed on the brain, spinal cord, and peripheral nerves. These procedures are typically carried out by neurosurgeons, who are medical doctors with specialized training in the diagnosis and treatment of disorders of the nervous system. Neurosurgical procedures can be used to treat a wide range of conditions, including traumatic injuries, tumors, aneurysms, vascular malformations, infections, degenerative diseases, and congenital abnormalities.
Some common types of neurosurgical procedures include:
* Craniotomy: A procedure in which a bone flap is temporarily removed from the skull to gain access to the brain. This type of procedure may be performed to remove a tumor, repair a blood vessel, or relieve pressure on the brain.
* Spinal fusion: A procedure in which two or more vertebrae in the spine are fused together using bone grafts and metal hardware. This is often done to stabilize the spine and alleviate pain caused by degenerative conditions or spinal deformities.
* Microvascular decompression: A procedure in which a blood vessel that is causing pressure on a nerve is repositioned or removed. This type of procedure is often used to treat trigeminal neuralgia, a condition that causes severe facial pain.
* Deep brain stimulation: A procedure in which electrodes are implanted in specific areas of the brain and connected to a battery-operated device called a neurostimulator. The neurostimulator sends electrical impulses to the brain to help alleviate symptoms of movement disorders such as Parkinson's disease or dystonia.
* Stereotactic radiosurgery: A non-invasive procedure that uses focused beams of radiation to treat tumors, vascular malformations, and other abnormalities in the brain or spine. This type of procedure is often used for patients who are not good candidates for traditional surgery due to age, health status, or location of the lesion.
Neurosurgical procedures can be complex and require a high degree of skill and expertise. Patients considering neurosurgical treatment should consult with a qualified neurosurgeon to discuss their options and determine the best course of action for their individual situation.